Oxford Nanopore Technologies - ONT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 303.75
  • Forecasted Upside: 210.27%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
GBX 97.90
▼ -0.55 (-0.56%)

This chart shows the closing price for ONT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oxford Nanopore Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONT

Analyst Price Target is GBX 303.75
▲ +210.27% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Oxford Nanopore Technologies in the last 3 months. The average price target is GBX 303.75, with a high forecast of GBX 355 and a low forecast of GBX 210. The average price target represents a 210.27% upside from the last price of GBX 97.90.

This chart shows the closing price for ONT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Oxford Nanopore Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/23/2024JPMorgan Chase & Co.Reiterated RatingOverweight
4/17/2024Berenberg BankReiterated RatingBuyGBX 350
4/12/2024CitigroupReiterated RatingBuyGBX 210
11/16/2023JPMorgan Chase & Co.Reiterated RatingOverweight
11/13/2023Royal Bank of CanadaLower TargetOutperformGBX 350 ➝ GBX 300
9/7/2023BarclaysReiterated RatingOverweightGBX 355
8/1/2023Berenberg BankReiterated RatingBuyGBX 529
6/7/2023CitigroupReiterated RatingBuyGBX 390
5/26/2023Berenberg BankReiterated RatingBuyGBX 529
4/17/2023Berenberg BankReiterated RatingBuyGBX 529
3/23/2023JPMorgan Chase & Co.Lower TargetOverweightGBX 460 ➝ GBX 390
3/22/2023Berenberg BankReiterated RatingBuyGBX 529
2/7/2023BarclaysLower TargetOverweightGBX 420 ➝ GBX 400
10/17/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
10/11/2022JPMorgan Chase & Co.Reiterated RatingOverweight
9/16/2022Berenberg BankReiterated RatingBuyGBX 671
8/8/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
8/8/2022Berenberg BankReiterated RatingBuyGBX 671
7/6/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
7/6/2022Berenberg BankReiterated RatingBuyGBX 671
6/8/2022Berenberg BankReiterated RatingBuyGBX 671
5/31/2022BarclaysLower TargetOverweightGBX 700 ➝ GBX 500
5/20/2022Berenberg BankReiterated RatingBuyGBX 671
5/9/2022Royal Bank of CanadaReiterated RatingOutperformGBX 400
3/29/2022JPMorgan Chase & Co.Lower TargetOverweightGBX 790 ➝ GBX 710
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 700
3/17/2022Berenberg BankReiterated RatingBuyGBX 662
3/15/2022BarclaysReiterated RatingOverweightGBX 700
2/4/2022Royal Bank of CanadaReiterated RatingOutperformGBX 750
2/3/2022Berenberg BankReiterated RatingBuyGBX 662
1/12/2022JPMorgan Chase & Co.Reiterated RatingOverweight
1/10/2022Royal Bank of CanadaLower TargetOutperformGBX 800 ➝ GBX 750
1/4/2022JPMorgan Chase & Co.Boost TargetOverweightGBX 725 ➝ GBX 790
12/16/2021BarclaysReiterated RatingOverweightGBX 700
12/3/2021Berenberg BankReiterated RatingBuyGBX 662
12/2/2021Royal Bank of CanadaReiterated RatingOutperformGBX 800
11/19/2021Royal Bank of CanadaReiterated RatingOutperformGBX 800
11/10/2021Berenberg BankInitiated CoverageBuyGBX 662
11/10/2021JPMorgan Chase & Co.Initiated CoverageOverweightGBX 725
11/10/2021Royal Bank of CanadaInitiated CoverageOutperformGBX 800
11/10/2021BarclaysInitiated CoverageOverweightGBX 700
(Data available from 6/14/2019 forward)

News Sentiment Rating

0.96 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/17/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/17/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/16/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/15/2024
  • 3 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/16/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/15/2024
  • 5 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/15/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/14/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Oxford Nanopore Technologies logo
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Read More

Today's Range

Now: GBX 97.90
Low: 97.90
High: 102.10

50 Day Range

MA: GBX 105.40
Low: 92.75
High: 115

52 Week Range

Now: GBX 97.90
Low: 91.24
High: 279

Volume

900,443 shs

Average Volume

1,081,065 shs

Market Capitalization

£844.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Nanopore Technologies?

The following sell-side analysts have issued research reports on Oxford Nanopore Technologies in the last twelve months: Barclays PLC, Berenberg Bank, Citigroup Inc., JPMorgan Chase & Co., and Royal Bank of Canada.
View the latest analyst ratings for ONT.

What is the current price target for Oxford Nanopore Technologies?

4 Wall Street analysts have set twelve-month price targets for Oxford Nanopore Technologies in the last year. Their average twelve-month price target is GBX 303.75, suggesting a possible upside of 210.3%. Barclays PLC has the highest price target set, predicting ONT will reach GBX 355 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of GBX 210 for Oxford Nanopore Technologies in the next year.
View the latest price targets for ONT.

What is the current consensus analyst rating for Oxford Nanopore Technologies?

Oxford Nanopore Technologies currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ONT will outperform the market and that investors should add to their positions of Oxford Nanopore Technologies.
View the latest ratings for ONT.

What other companies compete with Oxford Nanopore Technologies?

Other companies that are similar to Oxford Nanopore Technologies include BTG, Abcam, Genus, Ergomed and PureTech Health. Learn More about companies similar to Oxford Nanopore Technologies.

How do I contact Oxford Nanopore Technologies' investor relations team?

Oxford Nanopore Technologies' physical mailing address is Gosling Building, Edmund Halley Road Oxford Science Park, Oxford OX4 4DQ, United Kingdom. The company's listed phone number is 44 84 5034 7900. The official website for Oxford Nanopore Technologies is nanoporetech.com. Learn More about contacing Oxford Nanopore Technologies investor relations.